Institute Logo

  Institute Twain

Statistical Programming in Clinical Research



Preclinical research

Support in the phase 0 and in the phase 1:
• Experiments with microdoses
• Recommended dose of the molecule for the design and clinical research
• Toxicity and its restriction of the dose (dose limiting toxic effect, DLT)
• Effects of the pharmacokinetics and pharmacodynamics of the molecule
• Determination of healing effect



Clinical research, pharma

Support in the phase 2, phase 3 and later:
• experimental design, planning the study and the protocols
• adaptive methods
• ensuring the reproducibility and transparency
• biomarkers
• streamlining clinical trials









Institute Twain: the most favourable institute for statistical programming and statistical consulting in Germany